GPT and cancer: To maintain telomere length and integrity, human cancers lacking detectable telomerase activity (approx. 10–15%) may rely on the alternative telomere lengthening (ALT) mechanism [8], a homologous recombination (HR)-based process, which involves copying of telomeric DNA templates [9].